Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Clinical Risk Grouping Solution Market

Clinical Risk Grouping Solution Market Share

Report ID: GMI9982
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Clinical Risk Grouping Solution Market Share

The clinical risk grouping solution industry is characterized by intense competition among key players aiming to expand their market presence. Leading companies are focusing on strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their market position. These efforts are aimed at enhancing their service offerings, expanding their geographic reach, and investing in advanced technologies. The market also witnesses the entry of new players, intensifying the competitive landscape further.

Clinical Risk Grouping Solution Market Companies

Prominent players operating in the clinical risk grouping solution industry are as mentioned below:

3M Corporation
4S Dawn Clinical Software
Apixio
Cotiviti Inc.
Evolent
HBI Solutions
Health Catalyst, Inc.
HealthEC LLC
Lightbeam Health Solutions
MedeAnalytics, Inc.
Nuance Communications, Inc.
Optum, Inc.
RELX (LexisNexis Risk Solution)
ZeOmega

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Clinical risk grouping solution industry size was worth USD 673.4 million in 2023 and is projected to expand at 11.5% CAGR from 2024 to 2032, owing to the rise in prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer.

The software component segment in the clinical risk grouping solution industry accounted for USD 526.1 million in 2023 due to its ability to be customized according to the specific needs of different healthcare providers.

The population health management segment in the clinical risk grouping solution industry accumulated 33.2% market share in 2023 and is estimated to depict substantial growth between 2024 and 2032, due to the growing prevalence of chronic diseases.

North America clinical risk grouping solution industry accounted for 45.2% market share in 2023 and is projected to witness substantial gains from 2024 to 2032, led by the presence of strong technological structure with continuous innovation in healthcare.